close
icon-linkedin
icon-twitter
icon-facebook
icon-mail
icon-google-plus
icon-search
icon-phone
icon-instagram
Search
Main navigation
Services
All our services
Patents
Trademarks
Designs
IP Services
Sectors
All our sectors
Chemistry
Pharma
Life Sciences
Telecommunications & Software
Physics & Engineering
Focus groups
All our focus groups
Artificial Intelligence
EPO Case Law
Healthcare
U.S. Practice
Unitary Patent
Experts
About us
About us
Contact
NLO News
Secondary menu
Client stories
News & Articles
Podcasts
Working at NLO
Client Portal
Language
English
Nederlands
中文
한국어
Menu
What are you looking for?
Search
News and articles
Subscribe
Stay up to date with the latest IP news and expert insights from our patent and trademark attorneys. Don't miss out—subscribe to our newsletter today!
Filter on
Filter on
Filter on message type
All messages
Article
Blog
News
Case law
Podcast
Filter on tags
Artificial Intelligence
EPO Case Law
Client interview
Designs
EPO
Event
Healthcare
Life Sciences
Trademarks
News
Patents
Our history
Persbericht
Pharma
Press Release
Unitary Patent
Case law
14 Jun 2024
What is the extent of the duty of care in the apportionment of costs?
Patents
EPO Case Law
News
10 Jun 2024
NLO Netherlands and Belgium awarded Gold and Silver firm
News
10 Jun 2024
WTR Global Leaders 2024
Case law
4 Jun 2024
A party has the duty to fully explain its own objection of lack of novelty at each stage of the appeal procedure
EPO Case Law
Patents
News
3 Jun 2024
NLO Shieldmark experts have been awarded in IP Stars
Case law
29 May 2024
Assessment of admissibility of an inadmissibility request in T1006/21
EPO Case Law
Patents
News
23 May 2024
NLO Shieldmark Top tier firm | IP Stars 2024
Case law
16 May 2024
Second medical use claim: when is a specific subgroup of patients disclosed?
EPO Case Law
Patents
Case law
6 May 2024
Defining the invention by many parameters and complex conditions can amount to undue burden for skilled person
Patents
EPO Case Law
Pagination
Load more